Pelvic sentinel lymph node detection in high-risk endometrial cancer (SHREC-trial)—The final step towards a paradigm shift in surgical staging
European Journal of Cancer Jul 04, 2019
Persson J, et al. - A pelvic sentinel lymph node (SLN) algorithm was prospectively investigated for its diagnostic accuracy in high-risk endometrial cancer (HREC). Researchers adhered to an anatomically based algorithm after cervical injection of indocyanine green (ICG), with reinjection of tracer in case of non-display of predefined lymphatic pathways. A pelvic and infrarenal para-aortic lymphadenectomy was performed after removal of SLNs. Among 257 consecutive women with presumed FIGO stage I-II HREC who underwent robotic surgery at two academic centers by five accredited surgeons, pelvic lymph node metastases (LNMs) were observed in 54; of these, 52 were correctly identified by the SLN-ICG. Observations suggest that in the hands of experienced surgeons, the described pelvic SLN algorithm can exclude overall nodal involvement in 99% with a complete sensitivity to detect pelvic LNMs, and thereby can safely replace a full lymphadenectomy in HREC. The bilateral pelvic mapping rate increases with reinjection of tracer. They recommend primarily considering lower aortic tracer-positive nodes as echelon nodes. Reduction in true para-aortic skip metastases was noted with ultrasectioning of pelvic sentinel nodes.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries